Who is at risk of treatment failure and relapse in AML?
Вставка
- Опубліковано 25 січ 2022
- Learn more about AML at www.YouAndAML.com
Acute myeloid leukemia (AML) expert Dr. Barry Skikne explains that any person with AML is at risk for treatment failure and relapse in AML, however older persons tend to have an increased risk. In people over 60, treatment failure may be close to 50 percent. Patients can be stratified into low, intermediate, or poor risk disease based on the characteristics of their leukemia, and this stratification can help determine risk of treatment failure.
